Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 14;11(1):127.
doi: 10.1038/s41531-025-00981-6.

Differential memory enrichment of cytotoxic CD4 T cells in Parkinson's disease patients reactive to α-synuclein

Affiliations

Differential memory enrichment of cytotoxic CD4 T cells in Parkinson's disease patients reactive to α-synuclein

Antoine Freuchet et al. NPJ Parkinsons Dis. .

Abstract

Parkinson's disease (PD) is a complex neurodegenerative disease with a largely unknown etiology. Although the loss of dopaminergic neurons in the substantia nigra pars compacta is the pathological hallmark of PD, neuroinflammation also plays a fundamental role in PD pathology. We have previously reported that PD patients have increased frequencies of T cells reactive to peptides from α-synuclein (α-syn). However, not all PD participants respond to α-syn. Furthermore, we have previously found that CD4 T cells from PD participants responding to α-syn (PD_R) are transcriptionally distinct from PD participants not responding to α-syn (PD_NR). To gain further insight into the pathology of PD_R participants, we investigated surface protein expression of 11 proteins whose genes had previously been found to be differentially expressed when comparing PD_R and healthy control participants not responding to α-syn (HC_NR). We found that Cadherin EGF LAG seven-pass G-type receptor 2 (CELSR2) was expressed on a significantly higher proportion of CD4 effector memory T cells (TEM) in PD_R compared to HC_NR. Single-cell RNA sequencing analysis of cells expressing or not expressing CELSR2 revealed that PD_R participants have elevated frequencies of activated TEM subsets and an almost complete loss of cytotoxic TEM cells. Flow cytometry analyses confirmed that Granulysin+ CD4 cytotoxic TEM cells are reduced in PD_R. Taken together, these results provide further insight into the perturbation of T cell subsets in PD_R, and highlights the need for further investigation into the role of Granulysin+ CD4 cytotoxic TEM in PD pathology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. CELSR2+ cells are enriched in CD4 TEM in PD_R participants.
A Representative gating strategy of how CELSR2 + CD4 T cells were identified in four different memory subpopulations in HC_NR (n = 12) and PD_R (n = 12) participants. The frequency of CELSR2+ cells were identified for each of the four subpopulations. The complete gating strategy is displayed in Supplemental Fig. 1. B Frequency of memory (combined central memory (TCM): CD45RACCR7+; effector memory (TEM): CD45RACCR7; and effector memory T cells re-expressing CD45RA (TEMRA): CD45RA+CCR7) vs. naïve T cells (TN: CD45RA+CCR7+) among CELSR2+ cells. Results are represented as median with interquartile range. Mann–Whitney U-test. C Frequency of T cell memory subpopulations (TCM, TEM, and TEMRA) among memory CELSR2+ CD4 T cells. Results are represented as median with interquartile range. Two-way ANOVA and Tukey’s multiple comparisons test.
Fig. 2
Fig. 2. scRNAseq of CD4 TEM highlights distribution differences specific to CELSR2 expression and/or PD_R.
A Representative gating strategy for how CELSR2+ and CELSR2 TEM cells were identified and sorted from HC_NR (n = 4) and PD_R (n = 4) participants for subsequent scRNAseq analysis. B UMAP of CD4 TEM CELSR2 and CESLR2+ T cells. Cluster frequencies of Cluster 1—Differentiating TEM (C), Cluster 4—Cytotoxic TEM (D), and Cluster 6—Activated TEM (E) were analyzed and compared between HC_NR and PD_R in CD4 TEM expressing CELSR2 or not. Results are represented as median with interquartile range. Frequencies were compared using a paired t-test within PD_R or HC_NR samples, and an unpaired t-test to compare frequency between PD_R and HC_NR subgroups.
Fig. 3
Fig. 3. Overall expression of CELSR2 does not significantly impact transcriptomics, yet correlates with an enhanced cytotoxic gene signature in Cluster 4—Cytotoxic TEM in HC_NR.
Volcano plots comparing differential gene expression (DEG) of PD_R CELSR2+ vs PD_R CELSR2 in Cluster 1—Differentiating TEM (A) and HC_NR CELSR2+ vs HC_NR CELSR2 in Cluster 4—Cytotoxic TEM (B). Red points are significantly upregulated in CELSR2+ samples and blue points are significantly higher in CELSR2 samples (adjusted p value <0.05 and Log2 fold change >1). C Visualization of leukocyt-mediated cytotoxicity module score in CELSR2+ and CELSR2 cells from HC_NR participants. Data were represented as median, and p value obtained using an unpaired t-test. The score was created using genes both detected in this study and included in the leukocyte-mediated cytotoxicity biological process (GO:0001909). Volcano plots comparing differential gene expression (DEG) of PD_R CELSR2+ vs HC_NR CELSR2+ cells (D) and PD_R CELSR2 vs HC_NR CELSR2 cells in Cluster 1—Differentiating TEM (E). Red points are significantly upregulated in PD_R+ cells and blue points are significantly higher in HC_NR (adjusted p value <0.05 and Log2 fold change >1).
Fig. 4
Fig. 4. Cytotoxic T cells from PD_R are differentially enriched in TEM than HC_NR.
A Representative gating strategy for the identification of CD4 T cells expressing both Granzyme B (GzmB) and perforin, or Granulysin, and the further memory cell phenotyping of the cytotoxic cell subsets, in HC_NR (n = 11) and PD_R (n = 8) participants. Complete gating strategy is displayed in Supplemental Fig. 5. The frequencies of cytotoxic CD4 T cells identified by the double expression of GzmB and perforin (B) or Granulysin (C) were analyzed. Frequencies of TEM (CD45RACCR7) within GzmB+Perforin+ (D) and Granulysin+ (E) were analyzed. Results are represented as median with interquartile range. Mann–Whitney U-test.

References

    1. PAHO/WHO. Burden of neurological conditions. https://www.paho.org/en/enlace/burden-neurological-conditions (2022).
    1. Fahn, S. & Sulzer, D. Neurodegeneration and neuroprotection in Parkinson disease. NeuroRx1, 139–154 (2004). - PMC - PubMed
    1. Soto, C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat. Rev. Neurosci.4, 49–60 (2003). - PubMed
    1. Jankovic, J. Parkinson’s disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry79, 368–376 (2008). - PubMed
    1. Tansey, M. G. et al. Inflammation and immune dysfunction in Parkinson disease. Nat. Rev. Immunol.22, 657–673 (2022). - PMC - PubMed

LinkOut - more resources